» Articles » PMID: 18378173

Inflammatory Cytokines in Juvenile Idiopathic Arthritis: Effects on Physical Growth and the Insulin-like-growth Factor Axis

Overview
Publisher Elsevier
Specialty Endocrinology
Date 2008 Apr 2
PMID 18378173
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the relationship between markers of inflammation with physical growth and systemic markers of GH secretion in JIA.

Design: This is a cross sectional prospective study of patients with JIA recruited during therapeutic arthrocentesis of 17 children with JIA (F,10): 8 oligoarticular (OJIA) and 9 polyarticular (PJIA).

Results: Median adjusted height (AHt) SDS was -0.3 (-2.2 to 1.6). Serum ALS SDS (median -1.3, range -2.7 to -0.6) was reduced compared with serum IGFBP-3 SDS (median -0.5, range -7.7 to 2.3) and IGF-1 SDS (median -0.2, range -0.5 to 0.5). Log serum IL5 (95% CI -3.25, -0.81) and log serum IL15 (95% CI -9.58, -4.10) were independent factors associated with AHt SDS. Inflammatory cytokines individually showed no association with IGF-1, IGFBP-1, -2, -3 and ALS.

Conclusion: Children with JIA and mild degree of growth retardation show decreased ALS and IGFBP-3. Cytokines did not show an association to systemic markers of GH secretion. However, this study reports the novel, preliminary association between serum levels of IL5 and IL15 and the extent of short stature.

Citing Articles

Serum CS/DS, IGF-1, and IGFBP-3 as Biomarkers of Cartilage Remodeling in Juvenile Idiopathic Arthritis: Diagnostic and Therapeutic Implications.

Winsz-Szczotka K, Kuznik-Trocha K, Kozma E, Zeglen B, Gruenpeter A, Wisowski G Biomolecules. 2025; 14(12.

PMID: 39766233 PMC: 11673752. DOI: 10.3390/biom14121526.


Clinical outcomes of tocilizumab therapy in polyarticular and systemic juvenile idiopathic arthritis: a single-center analysis (2018-2022).

Gazda A, Naishtetik I, Kolodziejczyk B, Rybak K, Manczak M, Wojtowicz J Rheumatol Int. 2024; 44(12):2949-2959.

PMID: 39311914 PMC: 11618174. DOI: 10.1007/s00296-024-05711-4.


Identifying factors associated with substantially reduced adult height in patients with juvenile idiopathic arthritis: a retrospective cohort study.

Chen H, Hu Y, Yang Y, Chiang B BMC Pediatr. 2024; 24(1):375.

PMID: 38816849 PMC: 11137984. DOI: 10.1186/s12887-024-04855-3.


Tocilizumab for juvenile idiopathic arthritis: a single-center case series.

Yazilitas F, Ozdel S, Simsek D, Aydog O, Cakici E, Can G Sao Paulo Med J. 2020; 137(6):517-522.

PMID: 32159638 PMC: 9754278. DOI: 10.1590/1516-3180.2018.0489220719.


Insulin-Like Growth Factor Binding Proteins in Autoimmune Diseases.

Ding H, Wu T Front Endocrinol (Lausanne). 2018; 9:499.

PMID: 30214426 PMC: 6125368. DOI: 10.3389/fendo.2018.00499.